Novo Holdings A/S

CIK 0001388325 · HELLERUP, null · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

Novo Holdings A/S reported 25 positions worth $1.72B as of June 30, 2026 (13F filed August 14, 2026). Largest holding: EWTX (12.6%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$1.72B
2026 Q2
Positions
25
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
73.5%
Est. Net Flow (Q)
2026 Q2
10 / 25 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1EWTX EDGEWISE THERAPEUTICS INC SH$217.4M12.62%5,350,000
2ASML ASML HOLDING N V SH$188.9M10.97%94,946
3COAG HEMAB THERAPEUTICS HLDGS INC SH$153.6M8.92%4,180,550
4BN BROOKFIELD CORP SH$149.5M8.68%3,496,245
5MPLT MAPLIGHT THERAPEUTICS INC SH$132.1M7.67%3,686,622
6MIRM MIRUM PHARMACEUTICALS INC SH$131.7M7.65%1,125,000
7AVLN AVALYN PHARMACEUTICALS INC SH$127.8M7.42%3,883,289
8CRM SALESFORCE INC SH$61.6M3.58%393,187
9AVBP ARRIVENT BIOPHARMA INC SH$52.1M3.03%1,500,000
10ELVN ENLIVEN THERAPEUTICS INC SH$50.8M2.95%1,000,000

The free plan shows the top 10 positions. The remaining 15 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Novo Holdings A/S hold as of Q2 2026?

Novo Holdings A/S reported 25 positions worth $1.72B in its Q2 2026 13F filing. Largest positions: EWTX (12.6%), ASML (11.0%), COAG (8.9%), BN (8.7%) and MPLT (7.7%).

What did Novo Holdings A/S buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Novo Holdings A/S sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.